• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ultrasound Med Biol . Pulmonary Ultrasound in the Diagnosis and Monitoring of Coronavirus Disease (COVID-19): A Systematic Review

tetano

Editor, Senior Moderator
Ultrasound Med Biol


. 2021 Apr 20;S0301-5629(21)00190-3.
doi: 10.1016/j.ultrasmedbio.2021.04.011. Online ahead of print.
Pulmonary Ultrasound in the Diagnosis and Monitoring of Coronavirus Disease (COVID-19): A Systematic Review


Samuel Pecho-Silva[SUP] 1 [/SUP], Ana Claudia Navarro-Solsol[SUP] 2 [/SUP], Alvaro Taype-Rondan[SUP] 3 [/SUP], Javier Torres-Valencia[SUP] 4 [/SUP], Kovy Arteaga-Livias[SUP] 5 [/SUP], Daniel Albert Herriman[SUP] 6 [/SUP], Karim Acosta-Pinzas[SUP] 6 [/SUP], German Valenzuela-Rodriguez[SUP] 7 [/SUP], Joshuan J Barboza[SUP] 8 [/SUP], Vicky Panduro-Correa[SUP] 9 [/SUP]



Affiliations

Abstract

The goal of this review was to systematize the evidence on pulmonary ultrasound (PU) use in diagnosis, monitorization or hospital discharge criteria for patients with coronavirus disease 2019 (COVID-19). Evidence on the use of PU for diagnosis and monitorization of or as hospital discharge criteria for COVID-19 patients confirmed to have COVID-19 by reverse transcription polymerase chain reaction (RT-PCR) between December 1, 2019 and July 5, 2020 was compared with evidence obtained with thoracic radiography (TR), chest computed tomography (CT) and RT-PCR. The type of study, motives for use of PU, population, type of transducer and protocol, results of PU and quantitative or qualitative correlation with TR and/or chest CT and/or RT-PCR were evaluated. A total of 28 articles comprising 418 patients were involved. The average age was 50 y (standard deviation: 25.1 y), and there were 395 adults and 23 children. One hundred forty-three were women, 13 of whom were pregnant. The most frequent result was diffuse, coalescent and confluent B-lines. The plural line was irregular, interrupted or thickened. The presence of subpleural consolidation was noduliform, lobar or multilobar. There was good qualitative correlation between TR and chest CT and a quantitative correlation with chest CT of r = 0.65 (p < 0.001). Forty-four patients were evaluated only with PU. PU is a useful tool for diagnosis and monitorization and as criteria for hospital discharge for patients with COVID-19.

Keywords: B-Lines; COVID-19; Pulmonary ultrasound; Thoracic radiography; Thoracic tomography.
 
Back
Top Bottom